Enhanced bone morphogenetic protein-2 performance on hydroxyapatite ceramic surfaces

Journal of Biomedical Materials Research - Part A

Volumn 90, Issue 4, 2009, Pages 959-971

  Schuessele, A ^a   Mayr, H ^b   Tessmar, J ^a   Goepferich, A ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b Friedrich Baur Research Institute for Biomaterials   (Germany)

Author keywords

Biomimetic material; BMP 2; Ceramics; Hydroxyapatite; Surface modification

Indexed keywords

ALENDRONATE; ALKALINE PHOSPHATASE ACTIVITY; BIOLOGICAL PERFORMANCE; BIOMATERIAL SURFACES; BISPHOSPHONATES; BMP-2; BONE MORPHOGENETIC PROTEIN-2; CERAMIC DISCS; CERAMICS; CHELATING AGENT; ENZYMATIC ACTIVITIES; GROWTH FACTOR; HYDROXYAPATITE CERAMICS; IN-VITRO; IN-VIVO; MYOBLASTS; NOVEL METHODS; OSTEOBLASTIC DIFFERENTIATION; PAMIDRONATE; PROTEIN ACTIVITY; PROTEIN IMMOBILIZATION; SILANIZATIONS; SURFACE MODIFICATION; SURFACE MODIFICATION METHODS; SURFACE MODIFICATION TECHNIQUES;

APATITE; BIOMATERIALS; BIOMIMETICS; BONE; CALCIUM; CELL MEMBRANES; CERAMIC MATERIALS; CHELATION; ENZYMES; HYDROXYAPATITE; HYDROXYLATION; MOLECULAR BIOLOGY; PROTEINS; SURFACE TREATMENT;

BIOLOGICAL MATERIALS;

ALENDRONIC ACID; ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; HYDROXYAPATITE; IODINE 125; LYSOZYME; PAMIDRONIC ACID;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL STRUCTURE; CERAMIC PROSTHESIS; CHEMICAL REACTION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ISOTOPE LABELING; MOUSE; MYOBLAST; NONHUMAN; OSTEOBLAST; PROTEIN FUNCTION; PROTEIN IMMOBILIZATION;

ALENDRONATE; ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CELL DIFFERENTIATION; CELL LINE; CERAMICS; COATED MATERIALS, BIOCOMPATIBLE; DIPHOSPHONATES; DURAPATITE; IMMOBILIZED PROTEINS; MICE; MURAMIDASE; OSTEOBLASTS;

EID: 68249153278     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31745     Document Type: Article

References (70)

1. Puleo DA. Bone-implant interface. In: Encyclopedia of Biomaterials and Biomedical Engineering. New York: Marcel Dekker; 2004. p 190-198.
2. Shin H, Jo S, Mikos AG. Biomimetic materials for tissue engineering. Biomaterials 2003;24:4353-4364.
3. Hench LL, Polak JM. Third-generation biomedical materials. Science 2002;295:1014-1017.
4. Luginbuehl V, Meinel L, Merkle HP, Gander B. Localized delivery of growth factors for bone repair. Eur J Pharm Biopharm 2004;58:197-208.
5. Ripamonti U, Duneas N. Tissue morphogenesis and regeneration by bone morphogenetic proteins. Plast Reconstr Surg 1998;101:227-239.
6. Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins. Growth Factors 2004;22:233-241.
7. Jennissen HP. Accelerated and improved osteointegration of implants biocoated with bone morphogenetic protein 2 (BMP-2). Ann N Y Acad Sci 2002;961:139-142.
8. Akazawa T, Itabashi K, Murata M, Sasaki T, Tazaki J, Arisue M, Kobayashi M, Kanno T. Osteoinduction by functionally graded apatites of bovine origin loaded with bone morphogenetic protein-2. J Am Ceram Soc 2005;88:3545-3548.
9. Sachse A, Wagner A, Keller M, Wagner O, Wetzel WD, Layher F, Venbrocks RA, Hortschansky P, Pietraszczyk M, Wiederanders B. Osteointegration of hydroxyapatite-titanium implants coated with nonglycosylated recombinant human bone morphogenetic protein-2 (BMP-2) in aged sheep. Bone 2005;37:699-710.
10. Niedhart C, Maus U, Redmann E, Schmidt-Rohlfing B, Niethard FU, Siebert CH. Stimulation of bone formation with an in situ setting tricalcium phosphate/rhBMP-2 composite in rats. J Biomed Mater Res A 2003;65:17-23.
11. Liu Y, Hunziker EB, de Groot K, Layrolle P. Introduction of ectopic bone formation by BMP-2 incorporated biomimetically into calcium phosphate coatings of titanium-alloy implants. Key Eng Mater 2003;240-242:667-670.
12. Schmidmaier G, Wildemann B, Cromme F, Kandziora F, Haas NP, Raschke M. Bone morphogenetic protein-2 coating of titanium implants increases biomechanical strength and accelerates bone remodeling in fracture treatment: A biomechanical and histological study in rats. Bone 2002;30:816-822.
13. Kokubo S, Fujimoto R, Yokota S, Fukushima S, Nozaki K, Takahashi K, Miyata K. Bone regeneration by recombinant human bone morphogenetic protein-2 and a novel biodegradable carrier in a rabbit ulnar defect model. Biomaterials 2003;24:1643-1651.
14. Ruhe PQ, Boerman OC, Russel FGM, Spauwen PHM, Mikos AG, Jansen JA. Controlled release of rhBMP-2 loaded poly (D,L-lactic- co-glycolic acid)/calcium phosphate cement composites in vivo. J Controlled Rel 2005;106:162-171.
15. Uludag H, D'Augusta D, Palmer R, Timony G, Wozney J. Characterization of rhBMP-2 pharmacokinetics implanted with biomaterial carriers in the rat ectopic model. J Biomed Mater Res 1999;46:193-202.
16. Ziegler J, Mayr-Wohlfart U, Kessler S, Breitig D, Gunther KP. Adsorption and release properties of growth factors from biodegradable implants. J Biomed Mater Res 2002;59:422-428.
17. Voggenreiter G, Hartl K, Assenmacher S, Chatzinikolaidou M, Rumpf HM, Jennissen HP. Assessment of the biological activity of chemically immobilized rhBMP-2 on titanium surfaces in vivo. Materialwissenschaft und Werkstofftechnik 2001;32:942-948.
18. Park YJ, Kim KH, Lee JY, Ku Y, Lee SJ, Min BM, Chung CP. Immobilization of bone morphogenetic protein-2 on a nanofibrous chitosan membrane for enhanced guided bone regeneration. Biotechnol Appl Biochem 2006;43:17-24.
19. Hench LL. Bioceramics: From concept to clinic. J Am Ceram Soc 1991;74:1487-1510.
20. Sampathkumaran U, De Guire MR, Wang R. Hydroxyapatite coatings on titanium. Adv Eng Mater 2001;3:401-405.
21. Durrieu MC, Pallu S, Guillemot F, Bareille R, Amedee J, Baquey C, Labrugere C, Dard M. Grafting RGD containing peptides onto hydroxyapatite to promote osteoblastic cells adhesion. J Mater Sci: Mater Med 2004;15:779-786.
22. Schuessele A, Volk B, Mayr H, Blunk T, Schulz MB, Goepferichs A. Surface modification of hydroxyapatite ceramic to modulate cell adhesion and improve tissue generation. In: Proceedings of the 9th Seminar and Meeting on Ceramics, Cells and Tissues. Faenza, Italy; 2005. p 87-94.
23. de Groot K. Carriers that concentrate native bone morphogenetic protein in vivo. Tissue Eng 1998;4:337-341.
24. Rosengren A, Pavlovic E, Oscarson S, Krajewski A, Ravaglioli A, Piancastelli A. Plasma protein adsorption pattern on characterized ceramic biomaterials. Biomaterials 2002;23:1237-1247.
25. Lin JH. Bisphosphonates: A review of their pharmacokinetic properties. Bone 1996;18:75-85.
26. Uludag H, Kousinioris N, Gao T, Kantoci D. Bisphosphonate conjugation to proteins as a means to impart bone affinity. Biotechnol Prog 2000;16:258-267.
27. Uludag H, Gao T, Wohl GR, Kantoci D, Zernicke RF. Bone af-finity of a bisphosphonate-conjugated protein in vivo. Biotechnol Prog 2000;16:1115-1118.
28. Giuliani N, Pedrazzoni M, Negri G, Passeri G, Impicciatore M, Girasole G. Bisphosphonates stimulate formation of osteoblast precursors and mineralized nodules in murine and human bone marrow cultures in vitro and promote early osteoblastogenesis in young and aged mice in vivo. Bone 1998;22:455-461.
29. Im GI, Qureshi SA, Kenney J, Rubash HE, Shanbhag AS. Osteoblast proliferation and maturation by bisphosphonates. Biomaterials 2004;25:4105-4115.
30. Nancollas GH, Tang R, Phipps RJ, Henneman Z, Gulde S, Wu W, Mangood A, Russell RGG, Ebetino FH. Novel insights into actions of bisphosphonates on bone: Differences in interactions with hydroxyapatite. Bone 2006;38:617-627.
31. Kajiwara H, Yamaza T, Yoshinari M, Goto T, Iyama S, Atsuta I, Kido MA, Tanaka T. The bisphosphonate pamidronate on the surface of titanium stimulates bone formation around tibial implants in rats. Biomaterials 2005;26:581-587.
32. Tengvall P, Skoglund B, Askendal A, Aspenberg P. Surface immobilized bisphosphonate improves stainless-steel screw fixation in rats. Biomaterials 2004;25:2133-2138.
33. Puleo DA, Kissling RA, Sheu M-S. A technique to immobilize bioactive proteins, including bone morphogenetic protein-4 (BMP-4), on titanium alloy. Biomaterials 2002;23:2079-2087.
34. Klaeger AJ, Cevallos V, Sherman MD, Whitcher JP, Stephens RS. Clinical application of a homogeneous colorimetric assay for tear lysozyme. Ocul Immunol Inflamm 1999;7:7-15.
35. Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A, Suda T. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 1994;127:1755-1766.
36. Lieb E, Milz S, Vogel T, Hacker M, Dauner M, Schulz MB. Effects of transforming growth factor b1 on bonelike tissue formation in three-dimensional cell culture. I. Culture conditions and tissue formation. Tissue Eng 2004;10:1399-1413.
37. Lieb E, Vogel T, Milz S, Dauner M, Schulz MB. Effects of transforming growth factor b1 on bonelike tissue formation in three-dimensional cell culture. II. Osteoblastic differentiation. Tissue Eng 2004;10:1414-1425.
38. Kaelble DH, Moacanin J. A surface energy analysis of bioadhesion. Polymer 1977;18:475-482.
39. Vogler EA. Structure and reactivity of water at biomaterial surfaces. Adv Colloid Interface Sci 1998;74:69-117.
40. Norde W, Lyklema J. Why proteins prefer interfaces. J Biomater Sci Polym Ed 1991;2:183-202.
41. Daly SM, Przybycien TM, Tilton RD. Coverage-dependent orientation of lysozyme adsorbed on silica. Langmuir 2003; 19:3848-3857.
42. Lieb E, Tessmar J, Hacker M, Fischbach C, Rose D, Blunk T, Mikos AG, Goepferich A, Schulz MB. Poly(D,L-lactic acid)-poly(ethylene glycol)-monomethyl ether diblock copolymers control adhesion and osteoblastic differentiation of marrow stromal cells. Tissue Eng 2003;9:71-84.
43. Gopferich A, Peter SJ, Lucke A, Lu L, Mikos AG. Modulation of marrow stromal cell function using poly(D,L-lactic acid)-block-poly(ethylene glycol)-monomethyl ether surfaces. J Biomed Mater Res 1999;46:390-398.
44. Liu Q, de Wijn JR, van Blitterswijk CA. A study on the grafting reaction of isocyanates with hydroxyapatite filler particles. J Biomed Mater Res 1998;40:358-364.
45. Liu Q, de Wijn JR, de Groot K, van Blitterswijk CA. Surface modification of nano-apatite by grafting organic polymer. Biomaterials 1998;19:1067-1072.
46. Dong G, Sun J-S, Yao C-H, Jiang G-J, Huang C-W, Lin F-H. A study on grafting and characterization of HMDI-modified calcium hydrogenphosphate. Biomaterials 2001;22:3179-3189.
47. Liu Q, de Wijn JR, van Blitterswijk CA. Composite biomaterials with chemical bonding between hydroxyapatite filler particles and PEG/PBT copolymer matrix. J Biomed Mater Res 1998;40:490-497.
48. Weetall HH. Covalent coupling methods for inorganic support materials. Methods Enzymol 1976;44:134-148.
49. Puleo DA. Activity of enzyme immobilized on silanized Co-Cr-Mo. J Biomed Mater Res 1995;29:951-957.
50. Van Der Voort P, Vansant EF. Modification of the silica surface with aminosilanes. Polish J Chem 1997;71:550-567.
51. Halliwell CM, Cass AEG. A factorial analysis of silanization conditions for the immobilization of oligonucleotides on glass surfaces. Anal Chem 2001;73:2476-2483.
52. Wojcik SM, Puleo DA. Biochemical surface modification of Ti-6Al-4V for the delivery of protein to the cell-biomaterial interface. Biomed Sci Instrum 1997;33:166-171.
53. Bruening C, Grobe J. Aldehyde-functionalized ethoxysilanes as new enzyme immobilization reagents. J Chem Soc Chem Commun 1995;22:2323-2324.
54. Furuzono T, Sonoda K, Tanaka J. A hydroxyapatite coating covalently linked onto a silicone implant material. J Biomed Mater Res 2001;56:9-16.
55. Dupraz AMP, Meer SAT, de Wijn JR, Goedemoed JH. Biocompatibility screening of silane-treated hydroxyapatite powders, for use as filler in resorbable composites. J Mater Sci: Mater Med 1996;7:731-738.
56. Balasundaram G, Sato M, Webster TJ. Using hydroxyapatite nanoparticles and decreased crystallinity to promote osteoblast adhesion similar to functionalizing with RGD. Biomaterials 2006;27:2798-2805.
57. Meyer J, Nies B, Dard M, Hoelzemann G, Kessler H, Kantlehner M, Hersel U, Gibson C, Sulyok G. Peptide and peptide mimetic conjugates with integrin-inhibitor properties and usage for the integration of prosthetic materials. 2001;2001-EP8932:38.
58. Matsumoto T, Okazaki M, Inoue M, Hamada Y, Taira M, Takahashi J. Crystallinity and solubility characteristics of hydroxyapatite adsorbed amino acid. Biomaterials 2000;23:2241-2247.
59. Sawyer AA, Weeks DM, Kelpke SS, McCracken MS, Bellis SL. The effect of the addition of a polyglutamate motif to RGD on peptide tethering to hydroxyapatite and the promotion of mesenchymal stem cell adhesion. Biomaterials. Forthcoming.
60. Itoh D, Yoneda S, Kuroda S, Kondo H, Umezawa A, Ohya K, Ohyama T, Kasugai S. Enhancement of osteogenesis on hydroxyapatite surface coated with synthetic peptide (EEEEEEEPRGDT) in vitro. J Biomed Mater Res 2002;62:292-298.
61. Grabarek Z, Gergely J. Zero-length crosslinking procedure with the use of active esters. Anal Biochem 1990;185:131-135.
62. Chipman DM, Sharon N. Mechanism of lysozyme action. Science 1969;165:454-465.
63. Scheufler C, Sebald W, Hulsmeyer M. Crystal structure of human bone morphogenetic protein-2 at 2.7 A resolution. J Mol Biol 1999;287:103-115.
64. Raiche AT, Puleo DA. Cell responses to BMP-2 and IGF-I released with different time-dependent profiles. J Biomed Mater Res A 2004;69:342-350.
65. Cook SD, Thomas KA, Dalton JE, Volkman TK, Whitecloud TS III, Kay JF. Hydroxylapatite coating of porous implants improves bone ingrowth and interface attachment strength. J Biomed Mater Research 1992;26:989-1001.
66. Ozawa S, Kasugai S. Evaluation of implant materials (hydroxyapatite, glass-ceramics, titanium) in rat bone marrow stromal cell culture. Biomaterials 1996;17:23-29.
67. Stephenson PK, Freeman MA, Revell PA, Germain J, Tuke M, Pirie CJ. The effect of hydroxyapatite coating on ingrowth of bone into cavities in an implant. J Arthroplasty 1991;6:51-58.
68. Vasudev DV, Ricci JL, Sabatino C, Li P, Parsons R. In vivo evaluation of a biomimetic apatite coating grown on titanium surfaces. J Biomed Mater Res A 2004;69:629-636.
69. Yoshinari M, Oda Y, Ueki H, Yokose S. Immobilization of bisphosphonates on surface modified titanium. Biomaterials 2001;22:709-715.
70. Reinholz GG, Getz B, Pederson L, Sanders ES, Subramaniam M, Ingle JN, Spelsberg TC. Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts. Cancer Res 2000;60:6001-6007.